Betta Pharmaceuticals Co (SZSE:300558) FCF Margin % : -9.04% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Betta Pharmaceuticals Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Betta Pharmaceuticals Co's Free Cash Flow for the three months ended in Mar. 2024 was ¥-67 Mil. Betta Pharmaceuticals Co's Revenue for the three months ended in Mar. 2024 was ¥736 Mil. Therefore, Betta Pharmaceuticals Co's FCF Margin % for the quarter that ended in Mar. 2024 was -9.04%.

As of today, Betta Pharmaceuticals Co's current FCF Yield % is -0.52%.

The historical rank and industry rank for Betta Pharmaceuticals Co's FCF Margin % or its related term are showing as below:

SZSE:300558' s FCF Margin % Range Over the Past 10 Years
Min: -29.96 Med: -5.81 Max: 27.55
Current: -3.02

During the past 13 years, the highest FCF Margin % of Betta Pharmaceuticals Co was 27.55%. The lowest was -29.96%. And the median was -5.81%.

SZSE:300558's FCF Margin % is ranked worse than
57.81% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 0.235 vs SZSE:300558: -3.02

Betta Pharmaceuticals Co FCF Margin % Historical Data

The historical data trend for Betta Pharmaceuticals Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Betta Pharmaceuticals Co FCF Margin % Chart

Betta Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-4.21

-2.13

-10.32

-29.61

-7.40

Betta Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-31.61	-15.12	2.35	21.18	-9.04

Competitive Comparison of Betta Pharmaceuticals Co's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Betta Pharmaceuticals Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Betta Pharmaceuticals Co's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Betta Pharmaceuticals Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Betta Pharmaceuticals Co's FCF Margin % falls into.

Betta Pharmaceuticals Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Betta Pharmaceuticals Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-181.786	/	2456.196
	=	-7.40 %

Betta Pharmaceuticals Co's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-66.534	/	735.775
	=	-9.04 %

Betta Pharmaceuticals Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Betta Pharmaceuticals Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Betta Pharmaceuticals Co (SZSE:300558) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Betta Pharmaceuticals Co Ltd (SZSE:300558) » Definitions » FCF Margin %

Traded in Other Exchanges

N/A

Address

No.355, Xingzhong Road, Yuhang Economic and Technological Development Zone, Zhejiang Province, Hangzhou, CHN

Website

http://www.bettapharma.com

Betta Pharmaceuticals Co Ltd is a hi-tech pharmaceutical enterprise focuses on research and development of innovative medicines. The company's drug is used for various diseases such as malignant tumors, diabetes, and cardio-cerebrovascular disease. Further, it offers Icotinib hydrochloride, an orally administered small-molecule and a reversible tyrosine kinase inhibitor, which is used for the treatment of non-small-cell lung cancer. Geographically, the group operates through China.

Executives

Wang Jia Bing	Directors, executives
Ding Lie Ming	Directors, executives
Cai Wan Yu	Executives

Betta Pharmaceuticals Co (SZSE:300558) Headlines

No Headlines